The quiet rise of K18—a premium haircare brand with a scientific soul—offers a textbook case of what modern consumers want, and what luxury brands must now deliver. Not louder claims. Not flashier ...

Gov. J.B, Pritzker, the Illinois Department of Commerce and Economic Opportunity and Vantive announced today that the health ...

Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative ...

Cash, cash equivalents and marketable securities totaled $16.9M as of March 31 compared with $23.2M as of December 31, 2024. Unity believes ...

Theradaptive, a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, is pleased to announce the appointment of Daniel Wolf as Chief Financial Officer ...

CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making ...

LUMA Vision Ltd., an innovative leader in advanced cardiac imaging and navigation, today announced the FDA clearance of its VERAFEYEtm Visualization Platform. This novel catheter-based imaging system ...

A new AI IVF system has helped give birth to a healthy baby boy for the first time, and many hope it will make IVF more ...

Florida stands on the precipice of becoming a national leader in medical research and innovation, and we are seizing this ...

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on PRTG: Disclaimer & Disclosure Report an Issue Portage Biotech NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Health care and biotech startups are chasing the potential “superpowers” of artificial intelligence for applications as varied as novel protein development, clinical trials and patient records.

More than respect, probably it’s admiration. He's done it with a football club where everybody shares the vision, they have a very clear identity. “It's a club, a team that we can learn a lot from ...